MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer
1996

MYCL Genotypes and Lung Cancer

Sample size: 108 publication Evidence: moderate

Author Information

Author(s): KM Fong, Y Kida, PV Zimmerman, PJ Smith

Primary Institution: Queensland Cancer Fund Research Unit, Department of Pathology, University of Queensland Medical School

Hypothesis

Is the S allele of the MYCL oncogene associated with cancer susceptibility and prognosis in non-small-cell lung cancer?

Conclusion

The study found no evidence that MYCL genotypes were associated with tumor progression or worse prognosis in non-small-cell lung cancer patients.

Supporting Evidence

  • 108 cases of non-small-cell lung cancer were studied.
  • MYCL genotypes were identical in tumor and normal tissue of each patient.
  • 28% were homozygous for the L allele, 49% heterozygous, and 23% homozygous for the S allele.
  • Loss of heterozygosity at the MYCL locus was found in 27% of informative cases.

Takeaway

The S allele of the MYCL gene doesn't seem to affect how lung cancer grows or how long patients live after surgery.

Methodology

DNA was obtained from 108 cases of surgically resected non-small-cell lung cancer and normal lung tissue, and genotyping was performed using EcoRI RFLP.

Limitations

The study only investigated LOH at MYCL and did not map the critical region of genetic loss.

Participant Demographics

Patients with histologically diagnosed non-small-cell lung cancer who underwent curative surgery.

Statistical Information

P-Value

P=0.881

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication